APPLICATION OF UMMUNOMODULATORY THERAPY IN THE COMPLEX OF RELAPSE THERAPY OF HPV-ASSOCIATED INVASIVE AND MICROINVASIVE CERVICAL CANCER
https://doi.org/10.21518/2079-701X-2017-13-20-24
Abstract
Cervical cancer is one of the most common localized tumours of the female genital sphere. According to WHO, 16 710 new cases of cervical cancer were registered in Russia in 2015. 6,628 patients died of the progression of the malignant process of this localization in 2015. The standardized morbidity rate in 2015 was 15.1 per 100 thousand of population [1, 2].
About the Authors
Y. E. Dobrokhotova
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
MD, Prof.,
Moscow
M. G. Venediktova
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
MD,
Moscow
A. N. Sarantsev
Municipal Clinical Hospital No. 40, of the Health Сare Department of the City of Moscow
Russian Federation
Russian Federation
PhD in medicine,
Moscow
K. V. Morozova
Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
PhD in medicine,
Moscow
A. E. Zykov
Municipal Clinical Hospital No. 40, of the Health Сare Department of the City of Moscow
Russian Federation
Russian Federation
PhD in medicine,
Moscow
A. S. Khasan
Municipal Clinical Hospital No. 40, of the Health Сare Department of the City of Moscow
Russian Federation
Russian Federation
PhD in medicine,
Moscow
N. P. Panova
Municipal Clinical Hospital No. 40, of the Health Сare Department of the City of Moscow
Russian Federation
Russian Federation
PhD in medicine,
Moscow
Y. A. Savina
Municipal Clinical Hospital No. 40, of the Health Сare Department of the City of Moscow
Russian Federation
Moscow
Russian Federation
Moscow
V. A. Suvorova
Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
K. F. Orudzhova
Pirogov Russian National Research Medical University
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Злокачественые новообразования в России в 2015 году (Заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена, филиал ФГБУ «ФМИЦ им. П.А. Герцена» Минздрава России. 2017. 250 с.
2. Венедиктова М.Г., Доброхотова Ю.Э. Онкогинекология в практике гинеколога. М.: ГЭОТАР-Медиа, 2015. 288.
3. Орехова Е.К., Хачатурян А.Р. Современные возможности папилломавирусной инфекции: обзор мировых исследований. Журналъ акушерства и женскихъ болезней, 2014, LXII(3): 82–88.
4. Hua F, Liu S, Zhu L, Ma N, Jiang S, Yang J. Highly expressed long non-coding RNA NNT-AS1 promotes cell proliferation and invasion through Wnt/β-catenin signaling pathway in cervical cancer. Biomed Pharmacother. 2017 Jun 13; 92: 1128–1134.
5. Городецкая С.Б., Свешников П.Г., Бударина С.О. и др. Значение исследования уровня экспрессии онкобелка Е7 ВПЧ 16 и 18 типов в цервикальном материале в диагностике неопластических образований шейки матки. Молекулярная медицина. 5, 2010.
6. Baseman JG and Koutsky LA. The epidemiology of human papillomavirus infections. Journal of Clinical Virology, 2005, 32(1): 16–24.
7. Frasier L. D. Human papillomavirus infections of children. Pediatric Annals. 1994. 23. 354–360.
8. Philip J. Disaia, William T. Creasman. Клиническая онкогинекология. Пер. с англ.; под ред. Е.Г Новиковой. М.: ООО «Рид Элсивер», 2011. 1; Венедиктова М.Г., Доброхотова Ю.Э. Онкогинекология в практике гинеколога. М.: ГЭОТАР-Медиа, 2015. 288.
9. Wentzensen N, Litwin T. Accuracy of visual cervical screening: Verification bias revisited. BJOG. 2017 Jun 24. doi: 10.1111/1471– 0528.14797. American Society for Colposcopy and Cervical Pathology. Journal of Lower Genital Tract Disease, 2012, 16(3).
10. Wentzensen N, Litwin T. Accuracy of visual cervical screening: Verification bias revisited. BJOG. 2017 Jun 24.
11. Прилепская В.Н., Байрамова Г.Р., Коган Е.А., Чернова В.Ф., Окушко А.Н. Новые возможности ранней диагностики и профилактики ВПЧ-ассоциированных поражений шейки матки. Медицинский совет. Гинекология. Научный Центр акушерства, гинекологии и перинатологии им. В.И. Кулакова Минздрава России, М., 2015: 73–76.
12. Дисаи Ф.Дж., Крисман У.Т. Клиническая онкогинекология, под ред. Е.Г. Новиковой. М., 2012. 1. 316 с.
13. Xu H, Lin A, Shao X, Shi W, Zhang Y, Yan W. Diagnostic accuracy of high-risk HPV genotyping in women with high-grade cervical lesions: evidence for renewed the cervical cancer screening strategy in China. Oncotarget. 2016 Sep 10.
14. Chung SH. Cervical Cancer Screening after Perimenopause: How Is Human Papillomavirus Test Performed? J Menopausal Med. 2016 Aug; 22(2): 65–70.
Review
For citations:
Dobrokhotova YE, Venediktova MG, Sarantsev AN, Morozova KV, Zykov AE, Khasan AS, Panova NP, Savina YA, Suvorova VA, Orudzhova KF. APPLICATION OF UMMUNOMODULATORY THERAPY IN THE COMPLEX OF RELAPSE THERAPY OF HPV-ASSOCIATED INVASIVE AND MICROINVASIVE CERVICAL CANCER. Meditsinskiy sovet = Medical Council. 2017;(13):20-24. (In Russ.) https://doi.org/10.21518/2079-701X-2017-13-20-24
Views:
542
Email this article 